OMOP Concept 779674
bortezomib 2.5 MG Injection
StandardDrugRxNorm2601544Clinical Drug
Maps from
5
Descendants
4
Valid from
1 Aug 2022
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Source codes that map to this concept
5 source codes normalize to bortezomib 2.5 MG Injection via the OMOP "Maps to" relationship.
| Vocabulary | Code | Name | Type |
|---|---|---|---|
| NDC | 004091703 | bortezomib 2.5mg/1 INTRAVENOUS; SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Non-standard |
| NDC | 00409170301 | bortezomib 2.5 MG Injection | Non-standard |
| NDC | 680830651 | bortezomib 2.5mg/1 INTRAVENOUS; SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Non-standard |
| NDC | 68083065101 | bortezomib 2.5 MG Injection | Non-standard |
| VANDF | 4041435 | BORTEZOMIB 2.5MG/VIL INJ | Non-standard |
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(19)Roll up to these when you need a wider cohort.
- 1bortezomib 2.5 MG
- 1bortezomib Injectable Product
- 1bortezomib Injection
- 2bortezomib
- 2bortezomib
- 2BORTEZOMIB - bortezomib injection, powder, lyophilized, for solution
- 2Injectable Product
- 3Irritant
- 3Light-chain (AL) amyloidosis medication
- 3Proteasome inhibitor
- 3Proteasome inhibitors
- 3WHO Essential Cancer Medicine
- 4Drugs by local effect
- 4OTHER ANTINEOPLASTIC AGENTS
- 4Targeted therapeutic
- 4WHO Essential Medicine
- 5ANTINEOPLASTIC AGENTS
- 5Antineoplastics by class effect
- 6ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Narrower concepts
(4)Included automatically when you query with descendants.
Get this concept via the API
Resolve bortezomib 2.5 MG Injection - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/779674?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card